News & Trends - MedTech & Diagnostics
MTAA applauds Budget investment in homegrown innovations

MedTech & Diagnostics News: The Medical Technology Association of Australia (MTAA) has endorsed the Federal Budget measures for the Medical Science Co-Investment Plan.
Ed Husic MP, Minister for Industry and Science, and Mark Butler MP, Minister for Health and Aged Care, unveiled the Co-Investment Plan in mid-April. This initiative is part of a broader commitment to nurturing homegrown innovations and fostering a robust job market.
Within the Co-Investment Plan, medical science emerges as a focal point, highlighting medical devices, complex therapeutics, digital health, and sustainability as the primary investment opportunities. Its overarching objective is to bolster Australia’s medical science sector by facilitating the commercialisation of cutting-edge health technologies and enhancing the nation’s global competitiveness.
The Budget reflects a tangible commitment to this vision, with provisions totalling $18.8 million allocated to the National One Stop Shop for clinical trials and $1.4 billion earmarked for the Medical Research Future Fund.
Ian Burgess, CEO of MTAA, underscored the significance of these budgetary allocations, stating, “These Budget initiatives provide necessary support to the success of the Co-Investment Plan and other industry development initiatives, including the Industry Growth Program and National Reconstruction Fund (NRF).”
However, amidst the optimism, critics have raised concerns regarding the Plan’s potential limitations. Notably, while substantial investments are directed towards large-scale manufacturing facilities, challenges persist in competing with the lower transportation and labour costs prevalent in other countries.
Mr Burgess further expressed optimism regarding the role of the Co-Investment Plan and the National Reconstruction Fund in attracting investment from angel and venture capital investors, thereby fuelling the growth of medical device commercialization and emerging businesses.
“The Co-Investment Plan recognises the unique operating environment for medical device companies and sets out how government and industry can together leverage Australia’s strong medical device and related health science sectors. The Co-Investment Plan also recognises the importance of collaboration between industry, and government,” he stated.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals

New combination therapy improves survival rates for Aussies with advanced prostate cancer
A world-first treatment approach has demonstrated significant advancements in the management of metastatic castration-resistant prostate cancer (mCRPC) compared to conventional […]
MoreNews & Trends - Pharmaceuticals

‘Don’t just learn what illness is, learn what it feels like,’ Dr Ben Bravery
With the iconic Sydney Harbour as a backdrop, the Merck Healthcare team came together for a dynamic and engaging kick-off […]
MoreNews & Trends - MedTech & Diagnostics

GE HealthCare, Lumus Imaging and GenesisCare unite to bring advanced technology to patients
GE HealthCare and Lumus Imaging have joined forces to enhance medical care in Sydney’s Campbelltown region, unveiling a state-of-the-art imaging […]
MoreNews & Trends - MedTech & Diagnostics

World-First mobile CT for regional healthcare
An Australian X-ray technology company developing a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) […]
More